87 / 100 SEO Score

Dr.  Ahmed Bakillah | Diabetes | Best Researcher Award

Research Scientist at King Abdullah International Medical Research Center (KAIMRC),Saudi Arabia

A highly motivated and accomplished scientist with over 30 years of experience in biomedical research, focusing on diabetes, obesity, and cardiovascular diseases. With expertise spanning academia and the pharmaceutical industry, he has contributed significantly to translational medicine, identifying therapeutic targets for metabolic disorders. His leadership in research and editorial roles showcases his commitment to advancing scientific knowledge. Fluent in English, French, and Arabic, he has built strong global research networks. His work integrates cutting-edge biochemical, molecular, and cellular approaches to understand lipid metabolism and diabetes-related complications. His prolific publication record in high-impact journals and involvement in international research collaborations highlight his dedication to scientific excellence.

professional profiles📖

google scholar

Education 🎓

Dr. Ahmed Bakillah  holds a Doctorate Degree (Sc.D.) in Biochemistry from Chouaib Doukkali University (Morocco) in collaboration with the Medical College of Pennsylvania, awarded with Highest Honor for research on apoB-MTP interaction in lipoprotein metabolism. He earned a Ph.D. in Biochemistry from the University René Descartes of Paris V (France), focusing on Type IV collagen metabolism in diabetic microangiopathy. His Master’s Degree (DEA) in Cell Biology was obtained from the same institution, with a thesis on diabetic microvascular complications. He also earned a Bachelor’s Degree in Cell Biology from the University of Bourgogne (France). His academic background reflects a strong foundation in biochemical and molecular research, particularly in diabetes and metabolic disorders.

work Experience💼

Dr. Ahmed Bakillah  serves as a Research Scientist and Head of Research Academy & Laboratories at King Abdullah International Medical Research Center (KAIMRC-ER, Saudi Arabia). Previously, he was an Assistant Professor & Scientific Director for ECRIP at SUNY Downstate Medical Center (USA), where he led genetic research on cardiovascular diseases in African populations. He has held roles as a Senior Scientist & Research Assistant Professor at SUNY Downstate Medical Center, a Research Investigator at GlaxoSmithKline R&D (USA), and a Principal Scientist at Novo Nordisk A/S (Denmark). His career spans academia, clinical research, and industry, bridging basic and translational science

Research Focus

Dr. Ahmed Bakillah research investigates Type 2 diabetes and vascular complications, therapeutic approaches for obesity and insulin resistance, and the relationship between diabetes and cancer. He explores COVID-19 pathogenesis and cardiovascular complications, employing innovative translational medicine strategies to identify biomarkers for metabolic diseases. His work emphasizes lipid metabolism, lipoprotein abnormalities, and their impact on cardiovascular health.

Awards & Honors🏆 

Dr. Ahmed Bakillah accolades include being a Section Editor for JHPN, Guest Editor for Diseases/MDPI, and Managing Editor for Frontiers in Bioscience. He received the NIH Diversity Supplement Re-Entry Award (USA), the GSK Bronze Award for cardiovascular target discovery, and an NIH Postdoctoral Fellowship. He is a long-standing American Heart Association member and has won travel awards from Association Française du Tissu Conjonctif. His recognition includes the Irvine H. Page Arteriosclerosis Research Award and contributions to numerous editorial boards.

 Skills 🧠 

Dr. Ahmed Bakillah possesses strong expertise in biochemistry, molecular and cellular biology, particularly in diabetes and metabolic diseases. His skills include translational research, drug discovery, and biomarker development. He is adept in project management, scientific writing, peer-reviewing, and journal editorial management. With proficiency in English, French, and Arabic, he excels in scientific communication and collaboration.

Conclusion✅

Dr. Ahmed Bakillah is a highly deserving candidate for the Best Researcher Award, given his extensive contributions to biomedical research, mentorship, and editorial leadership. His work in diabetes and metabolic diseases has had a lasting impact on translational medicine and drug development. While there are areas where further expansion could strengthen his profile, his current achievements place him among the top contenders for this prestigious recognition.

📚Publications to Noted

The mammalian low-density lipoprotein receptor family

Authors: MM Hussain, DK Strickland, A Bakillah

Citations: 501

Year: 1999

Chylomicron assembly and catabolism: role of apolipoproteins and receptors

Authors: MM Hussain, RK Kancha, Z Zhou, J Luchoomun, H Zu, A Bakillah

Citations: 269

Year: 1996

Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B

Authors: UJF Tietge, A Bakillah, C Maugeais, K Tsukamoto, M Hussain, DJ Rader

Citations: 217

Year: 1999

Amino acids 430–570 in apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein

Authors: MM Hussain, A Bakillah, N Nayak, GS Shelness

Citations: 118

Year: 1998

The clinical potential of adipogenesis and obesity-related microRNAs

Authors: M Zaiou, H El Amri, A Bakillah

Citations: 104

Year: 2018

Decreased Secretion of ApoB Follows Inhibition of ApoB− MTP Binding by a Novel Antagonist

Authors: A Bakillah, N Nayak, U Saxena, RM Medford, MM Hussain

Citations: 92

Year: 2000

New approaches to target microsomal triglyceride transfer protein

Authors: MM Hussain, A Bakillah

Citations: 89

Year: 2008

Apolipoprotein B binding to microsomal triglyceride transfer protein decreases with increases in length and lipidation: implications in lipoprotein biosynthesis

Authors: MM Hussain, A Bakillah, H Jamil

Citations: 86

Year: 1997

Measurement of apolipoprotein B in various cell lines: correlation between intracellular levels and rates of secretion

Authors: A Bakillah, Z Zhou, J Luchoomun, MM Hussain

Citations: 58

Year: 1997

Assembly and secretion of VLDL in nondifferentiated Caco-2 cells stably transfected with human recombinant ApoB48 cDNA

Authors: J Luchoomun, Z Zhou, A Bakillah, H Jamil, MM Hussain

Citations: 45

Year: 1997

The role of microsomal triglyceride transfer protein in lipoprotein assembly: an update

Authors: A Bakillah, A El Abbouyi

Citations: 39

Year: 2003

Lysine and arginine residues in the N-terminal 18 of apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein

Authors: A Bakillah, H Jamil, MM Hussain

Citations: 38

Year: 1998

 

Ahmed Bakillah | Diabetes | Best Researcher Award

You May Also Like